Seven Eight Capital’s CareDx CDNA Stock Holding History

Seven Eight Capital’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,577	Closed	-$330K	–	113
2024 Q3	$330K	Buy	+10,577	New	+$263K	0.03%	632
2022 Q1	–	Sell	-12,321	Closed	-$560K	–	541
2021 Q4	$560K	Buy	12,321 +9,087	+281%	+$474K	0.1%	260
2021 Q3	$205K	Buy	3,234 +1,000	+45%	+$76.2K	0.02%	529
2021 Q2	$204K	Sell	2,234 -866	-28%	-$68.8K	0.03%	554
2021 Q1	$225K	Hold	3,100	–	–	0.05%	360
2020 Q4	$225K	Buy	+3,100	New	+$180K	0.05%	365
2020 Q1	–	Sell	-12,500	Closed	-$270K	–	486
2019 Q4	$270K	Sell	12,500 -49,086	-80%	-$1.13M	0.01%	587
2019 Q3	$1.39M	Buy	61,586 +41,280	+203%	+$1.14M	0.07%	370
2019 Q2	$731K	Buy	+20,306	New	+$650K	0.04%	443

Other funds holding CDNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Seven Eight Capital's CDNA Position: Q4 2024 in Review

Seven Eight Capital sold out of CareDx (CDNA) in Q4 2024, closing a stake of 10,577 shares — an estimated $330K sold.

Seven Eight Capital first reported a position in CDNA in Q2 2019 and held it in 9 quarters. The position peaked at $1.39M in Q3 2019. 210 funds tracked by Wall St. Rank hold CDNA as of Q4 2024.

Seven Eight Capital reported no remaining CareDx position as of Q4 2024 after selling out during the quarter.
Seven Eight Capital sold 10,577 CareDx shares in Q4 2024, an estimated $330K.
Seven Eight Capital first reported a position in CareDx in Q2 2019 and held it in 9 quarters.
Seven Eight Capital's CareDx position peaked at $1.39M in Q3 2019.
210 funds tracked by Wall St. Rank held CareDx as of Q4 2024.

Based on Seven Eight Capital's 13F filing for Q4 2024.